InvestorsHub Logo
Followers 9
Posts 2668
Boards Moderated 0
Alias Born 12/16/2013

Re: loanranger post# 47419

Thursday, 09/14/2017 10:22:20 AM

Thursday, September 14, 2017 10:22:20 AM

Post# of 97078
Loan,this is exactly the problem we're experiencing in today's news.

You took things out of context.

"Based on today's market reaction,......" Prefaced my observation and was a part of that sentence.

Now,if what you were implying was that the PR actually contained a negative "significance",vs a positive or even neutral one reflected by the reaction of the Market to the news in the PR(one that would be actually contrary to the hoped for reaction of a PR announcing a launch),then that's a whole nother matter.

I was simply commenting on the inferred importance DECN was attempting to convey by the issuance of a PR,and how the markets were "judging it".

I actually had the same thoughts cross my mind when I read the PR.

Isn't Diabetes Diabetes?

Your going to try to sell something to Third world Countries that isn't approved or sold in the United States?

Third World Countries is now the Pot of Gold DECN is sitting on?

Let's see,seeing that the inhabitants of TWCs have no money,DECN will have to sell these NON FDA approved Testing kits to TWC governments/Health organizations.

Think about it?

DECN,a $1 million in sales under capitalized loser of Millions
annually is going after this "target rich" environment?

Like I've said for a long time,the whole intention behind DECN is not to run a conventional company,it's to enrich a very few through
the illusion of a storefront.


Scoop



PS, Just imagine,Each Country will require Packaging in their own Countries language,and then there's The vast Infrastructure required to support Blood Glucose Testing in impoverished uneducated Countries?


PSS Wouldn't we already have some feedback on how DECN's Third World efforts have gone so far in Bolivia? Shouldn't we have a proven track record of "we've nailed it" kind of formulaic success to simply cookie cut off of? I must of missed that section in the Q2 financials.